Why perpetual COVID-19 vaccine boosting 'isn't an ideal option'
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
You are now subscribed
Your newsletter sign-up was successful
The prospect of COVID-19 booster shots have been looming since even before any vaccines were granted approval late last year. Most scientists believe boosters will be necessary at some point, though it's not clear when, but they also may want to make sure those bonus shots aren't needed all that often in the long run, Katherine Wu reported for The Atlantic on Wednesday.
"Boosting in perpetuity isn't an ideal option, if we can avoid it," Wu wrote. That's partly because side effects may become more intense with each passing shot, but it also may simply exhaust the human immune system. If people are vaccinated too frequently, then cells will eventually "stop learning efficiently from the material vaccines provide, and essentially 'burn out' from information overload," Wu reported, citing John Wherry, an immunologist at the University of Pennsylvania.
Ultimately, Wu wrote, "the world is better served when we're judicious with vaccines ... and inoculate as needed, no more, no less." Read more at The Atlantic.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
How the FCC’s ‘equal time’ rule worksIn the Spotlight The law is at the heart of the Colbert-CBS conflict
-
What is the endgame in the DHS shutdown?Today’s Big Question Democrats want to rein in ICE’s immigration crackdown
-
‘Poor time management isn’t just an inconvenience’Instant Opinion Opinion, comment and editorials of the day
-
A Nipah virus outbreak in India has brought back Covid-era surveillanceUnder the radar The disease can spread through animals and humans
-
Trump HHS slashes advised child vaccinationsSpeed Read In a widely condemned move, the CDC will now recommend that children get vaccinated against 11 communicable diseases, not 17
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
